Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFadel Partners Regulatory News (FADL)

Share Price Information for Fadel Partners (FADL)

Share Price is delayed by 15 minutes
Get Live Data
26.00    0.00 (0.00%)
Bid:
25.00
Ask:
27.00
Spread: 2.00 (8.00%)
Market Cap: £5.26m
FADL Live PriceLast checked at - London Stock Exchange

Intraday Fadel Partners Share Chart

Holding(s) in Company

13 May 2025 17:55

RNS Number : 5289I
Fadel Partners Inc.
13 May 2025
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

USU3033R1024

Issuer Name

FADEL PARTNERS, INC.

UK or Non-UK Issuer

Non-UK

2. Reason for Notification

Other

Comments

Please refer to the additional information section of the form for information - no change to the position.

3. Details of person subject to the notification obligation

Name

Maven Capital Partners UK LLP

City of registered office (if applicable)

Glasgow

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Name

City of registered office

Country of registered office

Maven Renovar VCT PLC

London

England and Wales

5. Date on which the threshold was crossed or reached

01-May-2025

6. Date on which Issuer notified

06-May-2025

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

10.298000

0.000000

10.298000

2083333

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

USU3033R1024

2083333

10.298000

Sub Total 8.A

2083333

10.298000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

Maven Renovar VCT PLC was previously Amati AIM VCT plc.The name change occurred following a change of Investment Manager from Amati Global Investors (AGI) to Maven Capital Partners UK LLP (Maven).There has been no change to the position held by the Company, the notification has been submitted for information on the name change only.

12. Date of Completion

06-May-2025

13. Place Of Completion

Glasgow

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLAJMFTMTABBIA
Date   Source Headline
30th Apr 20267:00 amRNSResults for the year ended 31 December 2025
20th Apr 20267:00 amRNSInvestor Presentation
28th Jan 20267:00 amRNS2025 Trading Update and FY 2026 Outlook
22nd Oct 20253:37 pmRNSGrant of Options
15th Oct 20252:38 pmRNSResult of AGM
14th Oct 20257:00 amRNSAGM and Trading Update
19th Sep 20257:00 amRNSNotice of AGM
5th Sep 20257:00 amRNSHalf-year Report
30th Jul 20257:00 amRNSHalf Year Trading Update
13th May 20255:55 pmRNSHolding(s) in Company
9th May 20257:00 amRNSDirector Share Dealings
7th May 20257:00 amRNSHolding(s) in Company
6th May 20257:00 amRNSDirector Share Dealings
30th Apr 20257:00 amRNSResults for the year ended 31 December 2024
3rd Feb 20257:00 amRNSEBT Share Purchase
27th Jan 20257:00 amRNS2024 Trading Update and FY 2025 Outlook
7th Nov 20247:00 amRNSUpdate to FY 25 Trading Expectations
25th Sep 20247:00 amRNSHalf Year Report
13th Sep 20247:00 amRNSInvestor Presentation via Investor Meet Company
20th Aug 20245:30 pmRNSResult of AGM
15th Aug 20247:00 amRNSRemoval of Regulation S Restrictions
31st Jul 20247:00 amRNSHalf Year Trading Update and Notice of AGM
2nd Jul 20247:00 amRNSBoard Appointment and Director Changes
14th Jun 20247:00 amRNSNotice of the postponement of AGM
3rd Jun 20247:00 amRNSNew Contract Wins
23rd May 20247:00 amRNSBoard Observer
10th May 20247:00 amRNSPosting of Annual Report and Notice of AGM
30th Apr 20247:00 amRNSResults for the year ended 31 December 2023
2nd Apr 20247:00 amRNSNotice of Results and Presentation
22nd Mar 20247:00 amRNSGrant of Options
1st Mar 20247:00 amRNSLaunch of LicenSeeâ„¢
26th Feb 20247:00 amRNSDirectorate Change
13th Feb 20247:00 amRNSDirectorate Change
31st Jan 20247:00 amRNSTrading Update
29th Nov 20237:00 amRNSResignation of Non-Executive Director
28th Nov 20237:00 amRNSMello Investor Presentations
27th Sep 20237:00 amRNSHalf-year Report
5th Sep 20237:00 amRNSNotice of Results and Investor Presentations
4th Aug 20237:00 amRNSExercise of Warrants and Total Voting Rights
25th Jul 20237:00 amRNSHalf Year Trading Update
21st Jul 20235:49 pmRNSResult of AGM
27th Jun 20237:00 amRNSInvestor Presentation
22nd Jun 20237:00 amRNSFinal Results and Notice of AGM
2nd May 20237:00 amRNSIssuance of Common Shares
20th Apr 20237:00 amRNSChange of Investment Manager/ Holdings in Company
12th Apr 20234:03 pmRNSHolding(s) in Company
11th Apr 20237:00 amRNSHolding(s) in Company
6th Apr 20237:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.